Einhaus, Jakob <br/><br/>
Inhibition of effector B cells by ibrutinib in systemic sclerosis.  [electronic resource] 

 -  Arthritis research & therapy  03 2020 
 - 66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/s13075-020-02153-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adult<br/>Agammaglobulinaemia Tyrosine Kinase--antagonists & inhibitors<br/>Aged<br/>Aged, 80 and over<br/>B-Lymphocytes--cytology<br/>Cells, Cultured<br/>Cytokines--metabolism<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>NF-kappa B--metabolism<br/>Phosphorylation--drug effects<br/>Piperidines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Scleroderma, Systemic--drug therapy